SkyOak Wealth, LLC - LINEAGE CELL THERAPEUTICS IN ownership

LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 90 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q4 2020. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
SkyOak Wealth, LLC ownership history of LINEAGE CELL THERAPEUTICS IN
ValueSharesWeighting
Q3 2023$17,700
-16.3%
15,0000.0%0.01%
-16.7%
Q2 2023$21,150
-6.0%
15,0000.0%0.01%
-14.3%
Q1 2023$22,500
+28.2%
15,0000.0%0.01%
+16.7%
Q4 2022$17,550
+3.2%
15,0000.0%0.01%0.0%
Q3 2022$17,000
-29.2%
15,0000.0%0.01%
-25.0%
Q2 2022$24,000
+4.3%
15,0000.0%0.01%
+33.3%
Q1 2022$23,000
-37.8%
15,0000.0%0.01%
-33.3%
Q4 2021$37,000
-2.6%
15,0000.0%0.01%
-10.0%
Q3 2021$38,000
-11.6%
15,0000.0%0.01%
-16.7%
Q2 2021$43,000
+7.5%
15,0000.0%0.01%
+9.1%
Q1 2021$40,000
+53.8%
15,0000.0%0.01%
+37.5%
Q4 2020$26,000
+85.7%
15,0000.0%0.01%
+60.0%
Q3 2020$14,000
+7.7%
15,0000.0%0.01%0.0%
Q2 2020$13,000
+8.3%
15,0000.0%0.01%
-16.7%
Q1 2020$12,000
-7.7%
15,0000.0%0.01%
+50.0%
Q4 2019$13,00015,0000.00%
Other shareholders
LINEAGE CELL THERAPEUTICS IN shareholders Q4 2020
NameSharesValueWeighting ↓
Defender Capital, LLC. 4,735,990$8,335,0003.63%
BROADWOOD CAPITAL INC 34,005,379$59,849,0003.55%
Prescott General Partners LLC 1,851,851$3,259,0000.14%
Strategic Wealth Investment Group, LLC 66,917$118,0000.07%
Laidlaw Wealth Management LLC 170,658$300,0000.06%
Humankind Investments LLC 26,737$47,0000.05%
DAFNA Capital Management LLC 80,000$141,0000.04%
Beirne Wealth Consulting Services, LLC 45,000$79,0000.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 680,839$1,198,0000.02%
Allegheny Financial Group LTD 20,000$35,0000.02%
View complete list of LINEAGE CELL THERAPEUTICS IN shareholders